Neurovascular regulation in the normal brain and in Alzheimer's disease

被引:0
|
作者
Costantino Iadecola
机构
[1] Weill Medical College of Cornell University,Division of Neurobiology
[2] room KB410,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The rate of cerebral blood flow (CBF) is positively correlated with brain activity. This 'functional hyperaemia' is mediated by the coordinated action of various vasoactive agents — including ions that are associated with synaptic transmission and some neurotransmitters — on blood vessels.The increases in CBF that are associated with neural activity are spatially restricted to the site of activity. Local interneurons and astrocytes are probably crucial to regulation of CBF at this level, producing and releasing vasoactive mediators.Vasodilation of extracerebral arteries that supply the site of neural activity is probably achieved through the upstream transmission of vasoactive signals within the walls of blood vessels.The 'neurovascular unit' — a functional entity comprising neurons, astrocytes, smooth muscle cells and endothelial cells — has a key role in the haemodynamic response to brain activity.Disruption of this regulatory network occurs in response to brain injury; for example, during stroke. Evidence now indicates that cerebrovascular dysfunction is a feature of neurodegenerative disorders such as Alzheimer's disease.Accumulation of amyloid β-peptide (Aβ) in brain is associated with neuronal death in Alzheimer's disease. Aβ induces dysfunction in all cell types of the neurovascular unit and interferes with the function of blood vessels. These effects are mediated through reactive oxygen species.
引用
收藏
页码:347 / 360
页数:13
相关论文
共 50 条
  • [1] Neurovascular regulation in the normal brain and in Alzheimer's disease
    Iadecola, C
    NATURE REVIEWS NEUROSCIENCE, 2004, 5 (05) : 347 - 360
  • [2] Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease
    Girouard, H
    Iadecola, C
    JOURNAL OF APPLIED PHYSIOLOGY, 2006, 100 (01) : 328 - 335
  • [3] Brain imaging of neurovascular dysfunction in Alzheimer’s disease
    Axel Montagne
    Daniel A. Nation
    Judy Pa
    Melanie D. Sweeney
    Arthur W. Toga
    Berislav V. Zlokovic
    Acta Neuropathologica, 2016, 131 : 687 - 707
  • [4] Brain imaging of neurovascular dysfunction in Alzheimer's disease
    Montagne, Axel
    Nation, Daniel A.
    Pa, Judy
    Sweeney, Melanie D.
    Toga, Arthur W.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2016, 131 (05) : 687 - 707
  • [5] Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
    Robert D. Bell
    Berislav V. Zlokovic
    Acta Neuropathologica, 2009, 118 : 103 - 113
  • [6] The neurovascular unit in Alzheimer's disease
    Taylor, S. L.
    Petzold, G.
    GLIA, 2019, 67 : E192 - E193
  • [7] Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease
    Bell, Robert D.
    Zlokovic, Berislav V.
    ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 103 - 113
  • [8] Calcium regulation in brain aging and Alzheimer's disease
    不详
    PHARMACOLOGICAL REPORTS, 2005, 57 (03) : 424 - 424
  • [9] The Neurovascular Unit Dysfunction in Alzheimer's Disease
    Soto-Rojas, Luis O.
    Pacheco-Herrero, Mar
    Martinez-Gomez, Paola A.
    Campa-Cordoba, B. Berenice
    Apatiga-Perez, Ricardo
    Villegas-Rojas, Marcos M.
    Harrington, Charles R.
    de la Cruz, Fidel
    Garces-Ramirez, Linda
    Luna-Munoz, Jose
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 27
  • [10] Neurovascular and cognitive failure in Alzheimer's disease
    Hamel, E.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 82 - 82